Medicure, Inc. (NASDAQ:MCUJF) | WebDisclosure

Basculer en Français

8295	Companies
114858	Keywords
55302	Articles
62445	Press releases

Home
Companies
Medicure, Inc.

BRIEF

published on 08/14/2024 at 23:05, 3 months 6 days ago

Medicure Reports Financial Results for Quarter Ended June 30, 2024

Financial Results Marley Drug Medicure AGGRASTAT ZYPITAMAG
PRESS RELEASE

published on 08/14/2024 at 23:00, 3 months 6 days ago

Medicure Reports Financial Results for Quarter Ended June 30, 2024
Medicure Inc. reports Q2 2024 financial results: net revenue down, EBITDA negative, net loss recorded. AGGRASTAT and ZYPITAMAG sales impacted. Analyst call on Aug 15, 2024

Financial Results EBITDA Medicure Inc. Net Loss Q2 2024
BRIEF

published on 06/24/2024 at 23:05, 4 months 26 days ago

Medicure annonce un accord d'acquisition avec CanAm Bioresearch Inc.

Médicament Propriété Intellectuelle Médicaments CanAm Biorecherche Achat D'actifs
BRIEF

published on 06/24/2024 at 23:05, 4 months 26 days ago

Medicure Announces Acquisition Agreement with CanAm Bioresearch Inc.

Pharmaceuticals Intellectual Property Asset Purchase Medicure CanAm Bioresearch
PRESS RELEASE

published on 06/24/2024 at 23:00, 4 months 26 days ago

Medicure Announces Signing of Asset Purchase Agreement with CanAm Bioresearch Inc. for Acquisition of Intellectual Property
Medicure Inc. announces asset purchase agreement with CanAm Bioresearch for acquisition of patent and intellectual property related to new chemical entities for therapeutic use

Medicure Inc. Asset Purchase Agreement CanAm Bioresearch New Chemical Entities Therapeutic Use
BRIEF

published on 05/28/2024 at 23:05, 5 months 23 days ago

Medicure Reports Financial Results for Q1 2024 and Director Election Results

Financial Results Director Election Q1 2024 Medicure
BRIEF

published on 05/28/2024 at 23:05, 5 months 23 days ago

Medicure publie ses résultats financiers pour le premier trimestre 2024 et les résultats de l'élection des administrateurs

Résultats Financiers Médicament T1 2024 Élection Du Directeur
PRESS RELEASE

published on 05/28/2024 at 23:00, 5 months 23 days ago

Medicure Reports Financial Results for Quarter Ended March 31, 2024 and Annual General Meeting Director Election Results
Medicure Inc. reports Q1 2024 financial results and director elections. Total revenue slightly up, AGGRASTAT® revenue down. Adjusted EBITDA decreased. New director appointed

Revenue Medicure Inc. Director Elections Q1 2024 Financial Results AGGRASTAT®
BRIEF

published on 04/23/2024 at 23:05, 6 months 27 days ago

Medicure reçoit la désignation Fast Track de la FDA pour le traitement MC-1 du déficit en PNPO

Medicure Inc. Désignation De Médicament Orphelin Désignation Fast Track De La FDA MC-1 Carence En PNPO
BRIEF

published on 04/23/2024 at 23:05, 6 months 27 days ago

Medicure Receives FDA Fast Track Designation for MC-1 Treatment for PNPO Deficiency

Medicure Inc. Orphan Drug Designation FDA Fast Track Designation MC-1 PNPO Deficiency

Accesswire

Published on 11/21/2024 at 12:00, 33 minutes ago

Alset AI Announces Full Repayment of $3.7 Million Secured Loan with Interest from Portfolio Company, Significantly Strengthening Balance Sheet
Published on 11/21/2024 at 12:00, 33 minutes ago

Battery X Metals Commences Strategic Initiatives to Strengthen Balance Sheet
Published on 11/21/2024 at 11:30, 1 hour 3 minutes ago

FireFox Trenching Returns More High-Grade Gold at the Mustajärvi Gold Project in Lapland, Finland
Published on 11/21/2024 at 10:03, 2 hours 30 minutes ago

Pixotope Launches Revolutionary AI-Powered Graphics Integration Tool for Broadcast Industry
Published on 11/21/2024 at 10:00, 2 hours 33 minutes ago

BluSky Carbon JV Entity BluMountain Enters into JV Partnership in Southeastern USA

View all ACCESSWIRE

EQS Group

Published on 11/21/2024 at 12:15, 18 minutes ago

Hardman & Co Investor Forum Research on Shield Therapeutics (STX): Proactive cash management to cashflow-breakeven
Published on 11/21/2024 at 12:06, 26 minutes ago

IVU AG publishes Quarterly Report Q3-2024
Published on 11/21/2024 at 12:00, 32 minutes ago

Holding(s) in Company
Published on 11/21/2024 at 11:30, 1 hour 3 minutes ago

APONTIS PHARMA AG: Condition of Minimum Acceptance in Zentiva’s Voluntary Public Purchase Offer Waived
Published on 11/21/2024 at 11:01, 1 hour 31 minutes ago

Original-Research: SMT Scharf AG (von Montega AG): Kaufen

Les Echos

Published on 11/21/2024 at 06:58, 5 hours 35 minutes ago

Net Asset Value per share increases with 9.4% in six months to EUR 55.6 thanks to continued strong growth performance of the portfolio
Published on 11/21/2024 at 06:58, 5 hours 35 minutes ago

Net Asset Value per share increases with 9.4% in six months to EUR 55.6 thanks to continued strong growth performance of the portfolio
Published on 11/21/2024 at 06:58, 5 hours 35 minutes ago

Netto-actiefwaarde per aandeel stijgt in zes maanden met 9,4% tot EUR 55,6 dankzij aanhoudend sterke groeiprestaties van portefeuille
Published on 11/20/2024 at 20:07, 16 hours 25 minutes ago

Entech : Nouveaux objectifs stratégiques à moyen-terme et Chiffre d’Affaires du 1er semestre 2024
Published on 11/20/2024 at 19:20, 17 hours 13 minutes ago

Peugeot Invest Board of Directors to evolve following the May 2025 Annual General Meeting

View all LES ECHOS COMFI WIRE